Community

Advertising Opportunities

 Biotechnology Europe Programs

 Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

 

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Terms of Business

Imprint

Privacy Policy

FAQ

Subscribe Newsletter

 

  BIOTECHNOLOGY EUROPE-ASIA NEWS    

 

 

 

   
   

   
 
 

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
18.12.2009 Prophylaxis of Influenza in Infants and Children Approved as an Additional Indication of Anti-influenza Drug Tamiflu®
 
16.10.2009 Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin® Application for Approval of Additional Indication of Breast Cancer
 
24.09.2009 Anti-Cancer Agent Xeloda® and Avastin® Obtained Approval for Additional Indication of Colorectal Cancer
 
18.09.2009 Antineoplastic Agent / Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, Tarceva® Application for Approval of Additional Indication of Pancreatic Cancer
 
07.09.2009 Supply Plan of "Tamiflu®" Anti-influenza Drug
 

03.12.2008 Conclusion of a joint research agreement between Chiome and Chugai:
Innovation in the research and development of therapeutic antibodies by means of the revolutionary "ADLib
® System" monoclonal antibody identification technology

 

26.11.2008 Anti-malignancy agent / anti-VEGF humanised monoclonal antibody, Avastin® Application for Approval of Additional Indication of NSCLC